Cargando…
Kinesin spindle protein inhibitors in cancer: from high throughput screening to novel therapeutic strategies
Bringing to a halt the cell cycle in mitosis and interfering with its normal progression is one of the most successful anti-cancer strategies used nowadays. Classically, several kinds of anti-cancer drugs like taxanes and vinca alkaloids directly inhibit microtubules during cell division. These drug...
Autores principales: | Shahin, Rand, Aljamal, Salah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890118/ https://www.ncbi.nlm.nih.gov/pubmed/35251692 http://dx.doi.org/10.2144/fsoa-2021-0116 |
Ejemplares similares
-
Triphenylbutanamines:
Kinesin Spindle Protein Inhibitors with in Vivo Antitumor Activity†
por: Wang, Fang, et al.
Publicado: (2012) -
Kinesin-related proteins required for assembly of the mitotic spindle
Publicado: (1992) -
The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma
por: Hernández-García, Susana, et al.
Publicado: (2017) -
Antibody–drug conjugates harboring a kinesin spindle protein inhibitor with immunostimulatory properties
por: Sommer, Anette, et al.
Publicado: (2022) -
Physiological evidence for involvement of a kinesin-related protein during anaphase spindle elongation in diatom central spindles
Publicado: (1992)